FOLDRX PHARMACEUTICALS
FoldRx Pharmaceuticals, Inc. engages in the discovery and development of disease modifying drug therapies for diseases of protein misfolding and amyloidosis. The companyТs pipeline includes a program in advanced clinical development to treat genetic neurologic and cardiovascular disorders, transthyretin-associated amyloidoses with polyneuropathy and TTR-associated amyloidoses with cardiomyopathy, and a discovery program in Parkinson's disease and cystic fibrosis. FoldRx Pharmaceuticals, Inc. was founded in 2003 and is based in Cambridge, Massachusetts.
FOLDRX PHARMACEUTICALS
Industry:
Biotechnology Genetics Health Care Medical
Founded:
2003-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.foldrx.com
Total Employee:
11+
Status:
Closed
Contact:
617-252-5500
Email Addresses:
[email protected]
Total Funding:
88 M USD
Technology used in webpage:
Verizon ColoCrossing
Similar Organizations
ArborGen
ArborGen grows and sells pine, eucalyptus and hardwood tree seedlings to the forestry industry.
Atamyo Therapeutics
Atamyo Therapeutics is focused on the development of a new generation of safe and effective gene therapies for neuromuscular diseases.
BIND Therapeutics
BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Inviragen
Inviragen is focused on developing life-saving vaccines to protect against emerging infectious diseases.
Protedyne Corporation
Provide support for all of its existing pharmaceutical, biotech and diagnostic testing customers.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
HealthCare Ventures
HealthCare Ventures investment in Venture Round - Foldrx Pharmaceuticals
Morgenthaler Ventures
Morgenthaler Ventures investment in Venture Round - Foldrx Pharmaceuticals
Novartis Venture Fund
Novartis Venture Fund investment in Venture Round - Foldrx Pharmaceuticals
F-Prime Capital
F-Prime Capital investment in Venture Round - Foldrx Pharmaceuticals
Alta Partners
Alta Partners investment in Venture Round - Foldrx Pharmaceuticals
TPG
TPG investment in Venture Round - Foldrx Pharmaceuticals
Novo Ventures
Novo Ventures investment in Venture Round - Foldrx Pharmaceuticals
Original Investors
Original Investors investment in Series B - Foldrx Pharmaceuticals
Novartis Venture Fund
Novartis Venture Fund investment in Series B - Foldrx Pharmaceuticals
F-Prime Capital
F-Prime Capital investment in Series B - Foldrx Pharmaceuticals
Official Site Inspections
http://www.foldrx.com
- Host name: 107-172-12-161-host.colocrossing.com
- IP address: 107.172.12.161
- Location: Buffalo United States
- Latitude: 42.8864
- Longitude: -78.8781
- Metro Code: 514
- Timezone: America/New_York
- Postal: 14202
